MGC Pharmaceuticals

Established in WA: 2015
1202 Hay Street, WEST PERTH, 6005
08 6382 3390
MGC Pharmaceuticals (ASX: MXC) is EU based specialist medical and cosmetic cannabis company with many years of technical and commercial experience in the medical cannabis industry. The Company’s founders were key figures in the Israeli medical cannabis industry and the core business strategy is to develop and supply high quality non-psychoactive Cannabinoid resin extract (“CBD”) to the growing European cosmetics and medical markets. The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
Bio last updated 02 Mar 2018

Article Timeline

Access to our data for MGC Pharmaceuticals is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

MGC Pharmaceuticals is included in 1 list - Public Companies - Industrial.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

To access ,

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer